SEELOS THERAPEUTICS, INC. financial data

Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 14 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12% % -82%
Debt-to-equity -114% % 52%
Return On Equity -13% % -103%
Return On Assets 93% %
Operating Margin -1480% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,956,903 shares -95%
Common Stock, Shares, Outstanding 3,322,045 shares -97%
Common Stock, Value, Issued $3,000 USD -98%
Weighted Average Number of Shares Outstanding, Basic 2,506,436 shares 356%
Weighted Average Number of Shares Outstanding, Diluted 2,515,400 shares 358%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,014,000 USD 12%
Research and Development Expense $20,431,000 USD -54%
General and Administrative Expense $11,391,000 USD -7.1%
Operating Income (Loss) $29,808,000 USD 46%
Nonoperating Income (Expense) $33,899,000 USD
Net Income (Loss) Attributable to Parent $4,091,000 USD
Earnings Per Share, Basic 50 USD/shares
Earnings Per Share, Diluted 49 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $188,000 USD -56%
Assets, Current $2,334,000 USD -80%
Operating Lease, Right-of-Use Asset $47,000 USD 6.8%
Assets $2,381,000 USD -80%
Accounts Payable, Current $15,686,000 USD 144%
Employee-related Liabilities, Current $471,000 USD -38%
Accrued Liabilities, Current $4,358,000 USD -22%
Liabilities, Current $30,514,000 USD -46%
Liabilities $30,514,000 USD -48%
Retained Earnings (Accumulated Deficit) $253,580,000 USD 1.6%
Stockholders' Equity Attributable to Parent $28,133,000 USD 40%
Liabilities and Equity $2,381,000 USD -80%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,642,000 USD 55%
Net Cash Provided by (Used in) Financing Activities $2,170,000 USD -76%
Common Stock, Shares Authorized 50,000,000 shares -90%
Common Stock, Shares, Issued 3,322,045 shares -97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,472,000 USD -68%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $294,000 USD -95%
Interest Paid, Excluding Capitalized Interest, Operating Activities $180,000 USD 58%
Operating Lease, Liability $47,000 USD 2.2%
Lessee, Operating Lease, Liability, to be Paid $48,000 USD 0%
Operating Lease, Liability, Current $47,000 USD 2.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $16,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $32,000 USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,000 USD -50%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $91,000 USD 550%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%